The future of precision medicine part 4: diagnosing the diagnostic problem
The development of precision treatments must be complemented by the development of precision diagnostics, as Daniel Lim of Kirkland & Ellis explains.
Latest genetics news
Eli Lilly unit accuses Alzheimer's institute of ‘malicious’ patent prosecution
14-08-2019
Avid Radiopharmaceuticals, a subsidiary of Eli Lilly, has taken the Alzheimer's Institute of America to court over its “malicious” prosecution of a patent infringement case.
